PATENT CLAIM ANALYSIS

Application Number: 15755262
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "054000"]

Abstract:
A pharmaceutical composition including N,N,N′,N′-tetrakis-(2-pyridylmethyl)-ethylenediamine (TPEN) or a pharmaceutically acceptable salt thereof, an alginate compound, and a pharmaceutically acceptable carrier. The pharmaceutical composition is useful for the treatment of hypoxia-related diseases.

Claim (Index 3):
The pharmaceutical composition of  claim 1 , wherein the average molecular weight of said alginate compound ranges from about 10 to about 300 kDa.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 88.0
- Lexical Diversity: 1.38235
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14255643', '14415163', '12594812', '15345842', '13809154']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7553078883880657
- 35 USC 102 Novelty (BERT): 0.4976727446523354
- Combined Prediction Score: 0.7295443740144927
- Mean Citation Score: 175.33369
- Max Citation Score: 187.93503
- Similarity Product: 120.16767550980808

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test